DK168627B1 - Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf - Google Patents

Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf Download PDF

Info

Publication number
DK168627B1
DK168627B1 DK095482A DK95482A DK168627B1 DK 168627 B1 DK168627 B1 DK 168627B1 DK 095482 A DK095482 A DK 095482A DK 95482 A DK95482 A DK 95482A DK 168627 B1 DK168627 B1 DK 168627B1
Authority
DK
Denmark
Prior art keywords
formula
acid
mdl
compounds
analogous process
Prior art date
Application number
DK095482A
Other languages
Danish (da)
English (en)
Other versions
DK95482A (da
Inventor
Richard C Dage
Frank P Palopoli
Richard A Schnettler
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK95482A publication Critical patent/DK95482A/da
Application granted granted Critical
Publication of DK168627B1 publication Critical patent/DK168627B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DK095482A 1981-03-05 1982-03-04 Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf DK168627B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US24088981 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use
US31431281 1981-10-23

Publications (2)

Publication Number Publication Date
DK95482A DK95482A (da) 1982-09-06
DK168627B1 true DK168627B1 (da) 1994-05-09

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK095482A DK168627B1 (da) 1981-03-05 1982-03-04 Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf

Country Status (18)

Country Link
US (1) US4405628A (es)
EP (1) EP0059948B1 (es)
KR (1) KR890000765B1 (es)
AT (1) ATE16489T1 (es)
AU (1) AU557590B2 (es)
CA (1) CA1190550A (es)
DE (1) DE3267352D1 (es)
DK (1) DK168627B1 (es)
ES (2) ES510087A0 (es)
GB (1) GB2096600B (es)
GR (1) GR76518B (es)
HK (1) HK61686A (es)
IE (1) IE52387B1 (es)
IL (1) IL65137A (es)
MY (1) MY8600700A (es)
NO (1) NO157175C (es)
NZ (1) NZ199885A (es)
PH (1) PH18345A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
CA1262732C (en) * 1984-07-30 1989-11-07 PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
GB2096600A (en) 1982-10-20
NZ199885A (en) 1985-04-30
MY8600700A (en) 1986-12-31
ES8305352A1 (es) 1983-04-16
ES510087A0 (es) 1983-04-16
HK61686A (en) 1986-08-29
GR76518B (es) 1984-08-10
CA1190550A (en) 1985-07-16
EP0059948B1 (en) 1985-11-13
IE52387B1 (en) 1987-10-14
AU557590B2 (en) 1986-12-24
IE820491L (en) 1982-09-05
ATE16489T1 (de) 1985-11-15
ES519254A0 (es) 1984-03-01
NO820686L (no) 1982-09-06
IL65137A (en) 1987-02-27
NO157175C (no) 1988-02-03
EP0059948A1 (en) 1982-09-15
NO157175B (no) 1987-10-26
IL65137A0 (en) 1982-05-31
GB2096600B (en) 1985-06-05
KR830009046A (ko) 1983-12-17
AU8103782A (en) 1982-09-09
DE3267352D1 (en) 1985-12-19
PH18345A (en) 1985-06-05
KR890000765B1 (ko) 1989-04-05
ES8402827A1 (es) 1984-03-01
DK95482A (da) 1982-09-06
US4405628A (en) 1983-09-20

Similar Documents

Publication Publication Date Title
DK168627B1 (da) Analogifremgangsmåde til fremstilling af (thio)pyridoylimidazol-2-(thi)oner eller et pharmaceutisk acceptabelt syre/baseadditionssalt deraf
JPH0236159A (ja) 化学化合物類
KR920000799B1 (ko) 신규아민류 및 그 용도
DE69007891T2 (de) 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one und -thione und ihre Verwendung bei der AIDS-Vorbeugung oder -Behandlung.
FI109696B (fi) Menetelmä sydämen rytmihäiriöiden ja värinän vastaisina aineina käyttökelpoisten 4-oksosyklisten ureayhdisteiden valmistamiseksi
EP0371805A2 (en) Piperidine derivatives and hypotensives containing the same
KR900000370B1 (ko) 티아졸론 및 이의 제조방법
CN111217833B (zh) 噻吩并[2,3-d]嘧啶类HIV-1非核苷类逆转录酶抑制剂及其制备方法和应用
EP2352501A1 (en) Compounds for the treatment of osteoporosis and cancers
CN114957296B (zh) 一类新型阿尔茨海默病检测探针及其生物应用
DK159424B (da) 5-acyl-2-(1h)-pyridinoner eller syreadditionssalte deraf
US4623651A (en) Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
JPS5885865A (ja) 新規な4−アロイルイミダゾリジン−2オン類
NO179909B (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
DK161251B (da) Analogifremgangsmaade til fremstilling af substituerede alkanoylimidazol-2-on-forbindelser
EP0226755B1 (en) 5-heterocyclic-3h-1,2,4-triazole-3-thiones and their use as antidepressants
CA1297107C (en) Process for the preparation of new 2-(2-thienyl)- imidazo(4,5-c)pyridine derivatives and pharmaceutically usable acid addition salts thereof
JPH0233032B2 (es)
KR960000073B1 (ko) 신규의 치환된 3-피페리딘아민 또는 3-아제핀아민, 그들의 제법 및 그들을 함유하는 약학적 조성물
NO160513B (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive aroylimidazoloner.
EP0336561B1 (en) 2-pyridylacetic acid derivatives, preparations thereof, and compositions containing them
JP2003026677A (ja) 3−フェニル−3,7−ジアザビシクロ[3,3,1]ノナン−化合物、これを含有する医薬品、その使用及びその製法
CA1246455A (en) Use of some 2-¬2-¬4-phenyl-1- piperazinyl|ethyl|-1h-naphth¬1,2-d|imidazole derivatives and their pharmaceutically acceptable salts in the treatment of cardiovascular diseases
AU2023211937A1 (en) Compositions for preventing or treating heart failure (hf)
EP0668276A1 (en) 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivative, process for producing the same, and use thereof

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed